Randomized trial comparing two fractionation schedules for patients with localized prostate cancer.

[1]  C. Orton.  In regard to Nahum et al. (Int J Radiat Oncol Biol Phys 2003;57:391-401): Incorporating clinical measurements of hypoxia into tumor control modeling of prostate cancer: implications for the alpha/beta ratio. , 2004, International journal of radiation oncology, biology, physics.

[2]  A. Nahum,et al.  Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio , 2003 .

[3]  H. Sandler,et al.  Surrogate end points for prostate cancer: what is prostate-specific antigen telling us? , 2003, Journal of the National Cancer Institute.

[4]  Ming-Hui Chen,et al.  Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. , 2003, Journal of the National Cancer Institute.

[5]  D. Kuban,et al.  Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy , 2003, World Journal of Urology.

[6]  A. Hanlon,et al.  Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone. , 2003, The Journal of urology.

[7]  David J Brenner,et al.  What hypofractionated protocols should be tested for prostate cancer? , 2002, International journal of radiation oncology, biology, physics.

[8]  C. Catton,et al.  The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systematic review. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  George Starkschall,et al.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.

[10]  Michael J. Zelefsky,et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.

[11]  Patrick A Kupelian,et al.  Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[12]  J. Epstein,et al.  Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? , 2001, The Journal of urology.

[13]  C. Reddy,et al.  Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. , 2001, International journal of radiation oncology, biology, physics.

[14]  Rick Chappell,et al.  Is α/β for prostate tumors really low? , 2001 .

[15]  G. Miller,et al.  Errors in histological grading by prostatic needle biopsy specimens: frequency and predisposing factors , 2000, The Journal of pathology.

[16]  G. Perry,et al.  Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. , 2000, International journal of radiation oncology, biology, physics.

[17]  D. Brenner.  Toward optimal external-beam fractionation for prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[18]  J. Zeng,et al.  Lateral biopsies added to the traditional sextant prostate biopsy pattern increases the detection rate of prostate cancer , 2000, Prostate Cancer and Prostatic Diseases.

[19]  M. Baumann.  Accelerated radiation therapy in non-small cell lung cancer. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Duchesne Gm,et al.  What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. , 1999 .

[21]  M. Zelefsky,et al.  Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma , 1999, Cancer.

[22]  D J Brenner,et al.  Fractionation and protraction for radiotherapy of prostate carcinoma. , 1999, International journal of radiation oncology, biology, physics.

[23]  W. J. Morris,et al.  PSA relapse definitions--the Vancouver Rules show superior predictive power. , 1999, International journal of radiation oncology, biology, physics.

[24]  R. Newcombe,et al.  Interval estimation for the difference between independent proportions: comparison of eleven methods. , 1998, Statistics in medicine.

[25]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[26]  J. Crook,et al.  Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate. , 1993, International journal of radiation oncology, biology, physics.

[27]  C. Catton,et al.  Carcinoma of the prostate: results of radical radiotherapy (1970-1985). , 1993, International journal of radiation oncology, biology, physics.

[28]  G. A. King,et al.  External beam radiotherapy for carcinoma of the prostate , 1989, Cancer.

[29]  G. Read,et al.  Retrospective study of radiotherapy in early carcinoma of the prostate. , 1989, British journal of urology.

[30]  A. V. von Eschenbach,et al.  The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate. , 1988, International journal of radiation oncology, biology, physics.

[31]  J. Kearsley.  High‐dose radiotherapy for localized prostatic cancer , 1986, The Medical journal of Australia.

[32]  J. Mcaninch,et al.  External beam radiotherapy for adenocarcinoma of the prostate: a clinical followup. , 1980, The Journal of urology.

[33]  D. Brenner,et al.  Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue , 2002 .

[34]  C. Perez,et al.  Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology. , 1988, NCI monographs : a publication of the National Cancer Institute.

[35]  Hanks Ge.  External-beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States. , 1988 .

[36]  F. Freiha,et al.  Carcinoma of the prostate: Results of post‐irradiation biopsy , 1984, The Prostate.